These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31884656)

  • 21. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
    Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
    J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators.
    Vogel RN; Davis DB; Kimura BH; Rathinavelu S; Graves GS; Szabo A; Han DP
    Retina; 2017 Feb; 37(2):257-264. PubMed ID: 27429385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying metamorphopsia in patients with diabetic macular oedema and other macular abnormalities.
    Achiron A; Lagstein O; Glick M; Gur Z; Bartov E; Burgansky-Eliash Z
    Acta Ophthalmol; 2015 Dec; 93(8):e649-53. PubMed ID: 25899144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Müller Glia Are a Major Cellular Source of Survival Signals for Retinal Neurons in Diabetes.
    Fu S; Dong S; Zhu M; Sherry DM; Wang C; You Z; Haigh JJ; Le YZ
    Diabetes; 2015 Oct; 64(10):3554-63. PubMed ID: 26068541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
    Saravia M; Zeman L; Ingolotti M; Schlaen A
    Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF).
    Sueishi K; Hata Y; Murata T; Nakagawa K; Ishibashi T; Inomata H
    Pol J Pharmacol; 1996; 48(3):307-16. PubMed ID: 9112668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
    Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Müller glia activation by VEGF-antagonizing drugs: An in vitro study on rat primary retinal cultures.
    Gaddini L; Varano M; Matteucci A; Mallozzi C; Villa M; Pricci F; Malchiodi-Albedi F
    Exp Eye Res; 2016 Apr; 145():158-163. PubMed ID: 26607807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ziv-aflibercept in macular disease.
    Mansour AM; Al-Ghadban SI; Yunis MH; El-Sabban ME
    Br J Ophthalmol; 2015 Aug; 99(8):1055-9. PubMed ID: 25677668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
    Bandello F; Corvi F; La Spina C; Benatti L; Querques L; Capuano V; Naysan J; Chen X; Sarraf D; Parodi MB; Souied E; Freund KB; Querques G
    Br J Ophthalmol; 2016 Dec; 100(12):1611-1616. PubMed ID: 26951773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
    Saleh R; Karpe A; Zinkernagel MS; Munk MR
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):817-824. PubMed ID: 28127658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
    Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
    Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes.
    Ye X; Ren H; Zhang M; Sun Z; Jiang AC; Xu G
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3481-9. PubMed ID: 22511624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.
    Stewart MW
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):167-80. PubMed ID: 24483136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.
    Pham B; Thomas SM; Lillie E; Lee T; Hamid J; Richter T; Janoudi G; Agarwal A; Sharpe JP; Scott A; Warren R; Brahmbhatt R; Macdonald E; Straus SE; Tricco AC
    BMJ Open; 2019 May; 9(5):e022031. PubMed ID: 31142516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic therapy for diabetic retinopathy.
    Gardlik R; Fusekova I
    Semin Ophthalmol; 2015 Jul; 30(4):252-63. PubMed ID: 24571780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autocrine and Paracrine Secretion of Vascular Endothelial Growth Factor in the Pre-Hypoxic Diabetic Retina.
    Grigsby JG; Allen DM; Ferrigno AS; Vellanki S; Pouw CE; Hejny WA; Tsin ATC
    Curr Diabetes Rev; 2017; 13(2):161-174. PubMed ID: 27748176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies.
    Li Y; Busoy JM; Zaman BAA; Tan QSW; Tan GSW; Barathi VA; Cheung N; Wei JJ; Hunziker W; Hong W; Wong TY; Cheung CMG
    Exp Eye Res; 2018 Sep; 174():98-106. PubMed ID: 29852133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.